The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Open accessAbstract
The antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, vascular thrombosis, and thrombocytopenia occurring in the presence of antiphospholipid (aPL) antibodies. The pathogenesis of fetal loss and tissue injury in APS is incompletely understood, but is thought to involve platelet and endothelial cell activation as well as procoagulant effects of aPL antibodies acting directly on clotting pathway components. Recent studies have shown that uncontrolled complement activation in the placenta leads to fetal death in utero. We hypothesized that aPL antibodies activate complement in the placenta, generating split products that mediate placental injury and lead to fetal loss and growth retardation. To test this hypothesis, we used a murine model of APS in which pregnant mice are injected with human IgG containing aPL antibodies. We found that inhibition of the complement cascade in vivo, using the C3 convertase inhibitor complement receptor 1–related gene/protein y (Crry)-Ig, blocks fetal loss and growth retardation. Furthermore, mice deficient in complement C3 were resistant to fetal injury induced by aPL antibodies. While antigenic epitopes recognized by aPL antibodies are important in the pathogenesis of APS, our data show that in vivo complement activation is required for aPL antibody-induced fetal loss and growth retardation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, E. N., Gharavi, A. E., Patel, S., & Hughes, G. R. (1987) · PubMed · Cited by 723
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
A Critical Role for Murine Complement Regulator Crry in Fetomaternal Tolerance
Xu, C., Mao, D., Holers, V. M., Palanca, B., Cheng, A. M., & Molina, H. (2000) · Science · doi:10.1126/science.287.5452.498 · Cited by 524
Self-citationBlank, M., Cohen, J., Toder, V, & Shoenfeld, Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3069 · Cited by 455
Hattori, R., Hamilton, K. K., McEver, R. P., & Sims, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81901-9 · Cited by 438
Activation of cultured vascular endothelial cells by antiphospholipid antibodies.
Simantov, R., LaSala, J. M., Lo, S. K., Gharavi, A. E., Sammaritano, L. R., Salmon, J. E., & Silverstein, R. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118276 · Cited by 420
Self-citationPierangeli, S. S., Colden-Stanfield, M., Liu, X., Barker, J. H., Anderson, G. L., & Harris, E. N. (1999) · Circulation · doi:10.1161/01.cir.99.15.1997 · Cited by 325
Self-citationMembrane attack by complement: the assembly and biology of terminal complement complexes
Tegla, C. A., Cudrici, C., Patel, S., Trippe, R., Rus, V., Niculescu, F., & Rus, H. (2011) · Immunologic Research · doi:10.1007/s12026-011-8239-5 · Cited by 321
Branch, D. W., Dudley, D. J., Mitchell, M. D., Creighton, K. A., Abbott, T. M., Hammond, E. H., & Daynes, R. A. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)90700-5 · Cited by 318
Di Simone, N., Meroni, P. L., Del Papa, N., Raschi, E., Caliandro, D., De Carolis, S., Khamashta, M. A., Atsumi, T., Hughes, G. R. V., Balestrieri, G., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<140::aid-anr18>3.0.co;2-p · Cited by 316
Papa, N. D., Guidali, L., Sala, A., Buccellati, C., Khamashta, M. A., Ichikawa, K., Koike, T., Balestrieri, G., Tincani, A., Hughes, G. R. V., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400322 · Cited by 289
Out, H. J., Kooijman, C. D., Bruinse, H. W., & Derksen, R. H. W. M. (1991) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(91)90021-c · Cited by 274
Benzaquen, L. R., Nicholson-Weller, A., & Halperin, J. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.985 · Cited by 261
Pierangeli, S. S., Liu, X. W., Barker, J. H., Anderson, G., & Harris, E. N. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649940 · Cited by 223
Self-citationKim, Y. U., Kinoshita, T., Molina, H., Hourcade, D., Seya, T., Wagner, L. M., & Holers, V. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.151 · Cited by 218
Self-citationStructure, function and cellular expression of complement anaphylatoxin receptors
Wetsel, R. A. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80028-x · Cited by 211
Circolo, A., Garnier, G., Fukuda, W., Wang, X., Hidvegi, T., Szalai, A. J., Briles, D. E., Volanakis, J. E., Wetsel, R. A., & Colten, H. R. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00021-1 · Cited by 166
Placental pathology in systemic lupus erythematosus: A prospective study
Magid, M. S., Kaplan, C., Sammaritano, L. R., Peterson, M., Druzin, M. L., & Lockshin, M. D. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70277-7 · Cited by 162
Holmes, C. H., Simpson, K. L., Okada, H., Okada, N., Wainwright, S. D., Purcell, D. F. J., & Houlihan, J. M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220635 · Cited by 157
Blockade of Antibody-Induced Glomerulonephritis with Crry-Ig, a Soluble Murine Complement Inhibitor
Quigg, R. J., Kozono, Y., Berthiaume, D., Lim, A., Salant, D. J., Weinfeld, A., Griffin, P., Kremmer, E., & Holers, V. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4553 · Cited by 144
Self-citationEffect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice
Pierangeli, S. S., Barker, J. H., Stikovac, D., Ackerman, D., Anderson, G. L., Barquinero, J., Acland, R. D., & Harris, E. N. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642501 · Cited by 138
Self-citationHolmes, C., Simpson, K. L., Wainwright, S., Tate, C., Houlihan, J., Sawyer, I. H., Rogers, I., Spring, F., Anstee, D., & Tanner, M. (1990) · Journal of Immunology · doi:10.4049/jimmunol.144.8.3099 · Cited by 130
Papa, N. D., Raschi, E., Moroni, G. L., Panzeri, P., Borghi, M. O., Ponticelli, C. E., Tincani, A., Balestrieri, G., & Meroni, P. L. (1999) · Lupus · doi:10.1177/096120339900800603 · Cited by 98
Tedesco, F., Narchi, G., Radillo, O., Meri, S., Ferrone, S., & Betterle, C. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1562 · Cited by 97
Antiphospholipid antibodies and complement activation in patients with cerebral ischemia.
Davis, W. D., & Brey, R. L. (1992) · PubMed · Cited by 97
Buyon, J. P., Tamerius, J. D., Ordorica, S. A., Young, B. K., & Abramson, S. B. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350109 · Cited by 96
Ikematsu, W., Luan, F., Rosa, L. L., Beltrami, B., Nicoletti, F., Buyon, J. P., Meroni, P. L., Balestrieri, G., & Casali, P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<1026::aid-art9>3.0.co;2-1 · Cited by 88
3 Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship
Holmes, C. H., & Simpson, K. L. (1992) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80005-7 · Cited by 80
Piona, A., Rosa, L. L., Tincani, A., Faden, D. F., Magro, G. G., GRASSO, S. G., Nicoletti, F., Balestrieri, G., & Meroni, P. L. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03588.x · Cited by 69
Decay-Accelerating Factor Protects Human Trophoblast from Complement-Mediated Attack
Cunningham, D. S., & Tichenor, J. R. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1023 · Cited by 58
Complement component deposition in utero-placental (spiral) arteries in normal human pregnancy
Wells, M. L., Bennett, J., Bulmer, J. N., Jackson, P., & Holgate, C. S. (1987) · Journal of Reproductive Immunology · doi:10.1016/0165-0378(87)90040-4 · Cited by 50
Obstetric Implications of Antiphospholipid Antibodies: Pregnancy Loss and Other Complications
Geis, W., & Branch, D. W. (2001) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200103000-00002 · Cited by 45
Immunology of reproduction: Protecting the placenta
Morgan, B. P., & Holmes, C. H. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00476-0 · Cited by 43
Shin, M. L., Rus, H., & Niculescu, F. I. (1996) · Biomembranes · doi:10.1016/s1874-5342(96)80007-9 · Cited by 38
Detection of Complement-fixing Antiphospholipid Antibodies in Association with Thrombosis
Saitô, T., Matsuda, K., Seino, J., Shibata, S., Sasaki, T., & Munakata, Y. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613900 · Cited by 37
Hypocomplementemia with low Cls‐Cl inhibitor complex in systemic lupus erythematosus
Lockshin, M. D., Qamar, T., Redecha, P. B., & Harpel, P. C. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291207 · Cited by 25
Affinity purified human antiphospholipid antibodies bind normal term placenta
Donohoe, S., Kingdom, J. C., & Mackie, I. J. (1999) · Lupus · doi:10.1191/096120399678840756 · Cited by 19
Cited by
The Pathogenesis of the Antiphospholipid Syndrome
Giannakopoulos, B., & Krilis, S. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1112830 · Cited by 688
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Self-citationComplement and coagulation: strangers or partners in crime?
Markiewski, M. M., Nilsson, B., Nilsson Ekdahl, K., Mollnes, T. E., & Lambris, J. D. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.006 · Cited by 645
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.52 · Cited by 620
“Immunohistochemical and histological examination of decidua showed deposition of human IgG and mouse complement, neutrophil infiltration and local TNF secretion, in association with a transient but significant increase in blood TNF levels”
BackgroundNew insights into mechanisms behind miscarriage
Larsen, E. C., Christiansen, O. B., Kolte, A. M., & Macklon, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-154 · Cited by 603
Metadata
- Authors
- Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., & Salmon, J. E.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-01-21
- Volume
- 195
- Issue
- 2
- Pages
- 211-220
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2097046783
- Cited by
- 626
- References
- 37
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.